What is the recommended management for avascular necrosis of the humeral head?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Avascular Necrosis of the Humeral Head

For early-stage humeral head AVN (stages 1-3) without collapse, pursue core decompression if the necrotic angle is ≥90 degrees, as humeral heads with necrotic angle <90 degrees do not collapse within 24 months and can be managed conservatively; for late-stage disease (stages 4-5) with articular collapse, perform hemiarthroplasty when glenoid cartilage is intact, or total shoulder arthroplasty when secondary osteoarthritis has developed 1.

Diagnostic Workup and Prognostic Assessment

Begin with plain radiographs (AP, lateral, and oblique views) to exclude fracture, primary arthritis, or tumor, though radiographs are insensitive for early disease 1. The critical prognostic factor is the necrotic angle measured on mid-coronal plane MRI—this determines whether the humeral head will collapse 1.

Key Prognostic Indicators:

  • Necrotic angle <90 degrees: No collapse expected in 24 months—conservative management appropriate
  • Necrotic angle ≥90 degrees: High risk of progression to collapse—consider surgical intervention
  • Additional risk factors for collapse: age >40 years, increased BMI (>24 kg/m²), joint effusion, and bone marrow edema 1

Important caveat: Humeral head AVN is frequently part of multifocal osteonecrosis—15% of patients on steroids develop shoulder involvement, and when present, check for concurrent hip (68%), knee (44%), and ankle (17%) involvement 1.

Treatment Algorithm by Stage

Early-Stage Disease (Stages 1-3, Pre-Collapse)

Conservative Management (necrotic angle <90°):

  • Risk factor modification (reduce corticosteroids if possible, alcohol cessation)
  • Physical therapy and activity modification
  • Anti-inflammatory medications
  • Close radiographic surveillance 2, 3

Surgical Intervention (necrotic angle ≥90° or symptomatic progression):

  • Core decompression is the primary joint-preserving option for early disease 1, 3
  • Can be supplemented with autologous bone marrow cells, vascular fibular grafting, or electrical stimulation
  • Critical limitation: Overall efficacy at preventing eventual articular collapse remains controversial 1
  • Advantage: Does not compromise future surgical options 4

Noninvasive therapies (statins, bisphosphonates, anticoagulants, extracorporeal shock wave therapy, hyperbaric oxygen) have limited supporting data and should not be primary treatment 1.

Late-Stage Disease (Stages 4-5, Post-Collapse)

Hemiarthroplasty (preferred when glenoid cartilage is intact):

  • Superior outcomes: Higher ASES scores (mean difference 17.12 points), significantly lower complication rates (RR 0.33), and better long-term durability with lower glenoid wear 5, 4
  • Complications include suture abscess, periprosthetic fracture, rotator cuff pathology, stiffness, and dislocation 5
  • Preserves future revision options 6

Total Shoulder Arthroplasty (when secondary osteoarthritis present):

  • Indicated when glenoid cartilage is damaged with established glenohumeral arthropathy 1, 3
  • Provides greater external rotation (mean difference 10.23°) but higher complication rates 5
  • Pain relief and revision rates are comparable between TSA and hemiarthroplasty 5

Resurfacing arthroplasty is an alternative option for late-stage disease 1.

Critical Decision Points

The 2022 ACR Appropriateness Criteria 1 emphasize that early diagnosis is crucial to: (1) exclude other pain causes and (2) enable early surgical prevention of articular collapse and joint replacement. However, the evidence reveals a fundamental tension: while core decompression aims to prevent collapse, its efficacy remains controversial, and many patients ultimately progress to arthroplasty regardless 1.

Common Pitfalls:

  • Underestimating disease extent: Always assess for multifocal involvement in nontraumatic cases
  • Delaying imaging: Plain films miss early disease—use MRI for definitive diagnosis and staging
  • Overestimating core decompression: While it preserves future options, it does not reliably prevent collapse in high-risk lesions
  • Wrong arthroplasty choice: Hemiarthroplasty consistently outperforms TSA when glenoid is intact 5, 4

Posttraumatic AVN (following proximal humerus fractures) requires surgical intervention more often than idiopathic AVN and should be managed more aggressively 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.